- Home
- NBH vs CRMD Comparison
NBH vs CRMD Comparison
Compare NBH & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBH
- CRMD
- Stock Information
- Founded
- NBH 2002
- CRMD 2006
- Country
- NBH United States
- CRMD United States
- Employees
- NBH N/A
- CRMD N/A
- Industry
- NBH Finance/Investors Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- NBH Finance
- CRMD Health Care
- Exchange
- NBH Nasdaq
- CRMD Nasdaq
- Market Cap
- NBH 288.5M
- CRMD 877.5M
- IPO Year
- NBH N/A
- CRMD 2010
- Fundamental
- Price
- NBH $9.87
- CRMD $11.28
- Analyst Decision
- NBH
- CRMD Strong Buy
- Analyst Count
- NBH 0
- CRMD 7
- Target Price
- NBH N/A
- CRMD $17.33
- AVG Volume (30 Days)
- NBH 85.9K
- CRMD 2.3M
- Earning Date
- NBH 01-01-0001
- CRMD 08-13-2025
- Dividend Yield
- NBH 4.34%
- CRMD N/A
- EPS Growth
- NBH N/A
- CRMD N/A
- EPS
- NBH 0.12
- CRMD 0.28
- Revenue
- NBH N/A
- CRMD $82,553,827.00
- Revenue This Year
- NBH N/A
- CRMD $238.38
- Revenue Next Year
- NBH N/A
- CRMD $53.52
- P/E Ratio
- NBH $87.04
- CRMD $40.42
- Revenue Growth
- NBH N/A
- CRMD N/A
- 52 Week Low
- NBH $8.75
- CRMD $3.61
- 52 Week High
- NBH $11.01
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- NBH 47.91
- CRMD 39.54
- Support Level
- NBH $9.79
- CRMD $11.13
- Resistance Level
- NBH $9.97
- CRMD $11.86
- Average True Range (ATR)
- NBH 0.06
- CRMD 0.65
- MACD
- NBH 0.01
- CRMD -0.34
- Stochastic Oscillator
- NBH 44.44
- CRMD 3.81
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.